Amyloidosis and its Management: Amyloid Neuropathies | oneAMYLOIDOSISvoice
×
Or register here
Global Search

Trusted Resources: Education

Scientific literature and patient education texts

Back to Education / Scientific Articles

Amyloidosis and its Management: Amyloid Neuropathies

key information

source: Current Problems in Cancer

year: 2016

authors: Pearson KT, Vota S

summary/abstract:

The amyloid neuropathies are rare, rapidly progressive systemic disorders that often are misdiagnosed when initially presenting as a peripheral neuropathy.1 Light chain (AL) amyloidosis, an acquired disorder, and familial amyloid polyneuropathy, a hereditary disorder, may each cause severe and disabling peripheral neuropathies, in addition to other systemic manifestations.

Diagnosis may be delayed, especially in the familial amyloid neuropathies (FAP), based on atypical presentation, late onset, or lack of positive family history. Early diagnosis is imperative as there are available therapies that may slow disease progression. This review will focus on the presentation, diagnosis, pathology, and treatment of both the FAP and light chain (AL) amyloidosis to encourage and assist in more rapid diagnosis and early intervention.

organization: Virginia Commonwealth University, USA

DOI: 10.1016/j.currproblcancer.2016.08.001

read more full text

Related Content

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close

Community Key Collaborator

Support for this landing page is provided by an independent education grant from

Translation of this platform made possible through an independent education grant from

© 2024 rareLife solutions Inc.

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close